The ratio of PKM1/PKM2 is the key factor affecting the glucose metabolism and biological function of colorectal cancer cells
Authors:
- Liang MaLMLiang Ma
- Xue ZhangXZXue Zhang
- Yan LiuYLYan Liu
- Hui JinHJHui Jin
- Dan LiDLDan Li
- Hui ZhangHZHui Zhang
- Li FengLFLi Feng
- Jing ZuoJZJing Zuo
- Yudong WangYWYudong Wang
- Jiayin LiuJLJiayin Liu
- Jing HanJHJing Han
Open Access
- 1 July 2024
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 13 (7) , 3522-3535
Abstract
Review Article Recent advances and challenges in primary central nervous system lymphoma: a narrative review Le Ma, Qiang GongKeywords
This publication has 38 references indexed in Scilit:
- CaMeRe: A Novel Tool for Inference of Cancer Metabolic ReprogrammingFrontiers in Oncology, 2020
- Emerging role of Fatty acid synthase in tumor initiation: implications for cancer preventionMolecular & Cellular Oncology, 2020
- The PI3K–AKT network at the interface of oncogenic signalling and cancer metabolismNature Reviews Cancer, 2019
- Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1European Journal of Pharmacology, 2019
- Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg EffectFrontiers in Cell and Developmental Biology, 2018
- Differentially expressed lncRNAs and mRNAs identified by NGS analysis in colorectal cancer patientsCancer Medicine, 2018
- Oncogenic Roles of the PI3K/AKT/mTOR Axis2017
- Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancerOncology Reports, 2016
- Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal CancerMolecular & Cellular Proteomics, 2016
- Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to AntiangiogenicsCell Reports, 2016